MedPath

TRIKAFTA

TRIKAFTA

Approved
DIN Number

02517140

Drug Class

Human

Market Date

Jun 22, 2021

Company
HC

Vertex Pharmaceuticals (Canada) Incorporated

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02517140
AIG Number0462989001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
R07AX32 IVACAFTOR, TEZACAFTOR AND ELEXACAFTOR
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification48:14.12
Health Canada Classification

ACTIVE INGREDIENTS (4)

ELEXACAFTORActive
Strength: 100 MG
Monograph: ELEXACAFTOR
IVACAFTORActive
Strength: 150 MG
Monograph: IVACAFTOR
IVACAFTORActive
Strength: 75 MG
Monograph: IVACAFTOR
TEZACAFTORActive
Strength: 50 MG
Monograph: TEZACAFTOR

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.